1. Division of Therapeutics and Molecular Medicine; University of Nottingham; Nottingham NG7 2UH UK
2. Division of Epidemiology and Public Health; University of Nottingham; Nottingham NG5 1PB UK
3. West Midlands Centre for Adverse Drug Reactions; City Hospital; Birmingham B18 7QH UK
4. Department of Diabetes and Endocrinology; Nottingham University Hospitals NHS Trust; Nottingham NG7 2UH UK
5. Endocrine Hypertension Research Centre; University of Queensland School of Medicine; Brisbane Australia
6. Clinical Pharmacology Unit; Department of Medicine; University of Cambridge; Cambridge CB2 2QQ UK